Pregled bibliografske jedinice broj: 1088770
First experience of alpelisib treatment of HR+ HER2- metastatic breast carcinoma in Croatia
First experience of alpelisib treatment of HR+ HER2- metastatic breast carcinoma in Croatia // Libri oncologici : Croatian journal of oncology, 18 (2020), 1; 121-121 (domaća recenzija, prikaz, ostalo)
CROSBI ID: 1088770 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
First experience of alpelisib treatment of HR+ HER2-
metastatic breast carcinoma in Croatia
Autori
Pancirov, Marija ; Majić, Ana ; Tomić, Snježana ; Dolić, Krešimir, Krnić, Mladen ; Petrić Miše, Branka ; Vrdoljak, Eduard
Izvornik
Libri oncologici : Croatian journal of oncology (0300-8142) 18
(2020), 1;
121-121
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, prikaz, ostalo
Ključne riječi
Metastatic breast cancer, PIK3Ca mutation, Alpelisib
(Metastatic breast cancer, PIK3Ca mutation, alpelisib)
Sažetak
Case report
Izvorni jezik
Engleski
POVEZANOST RADA
Profili:
Snježana Tomić
(autor)
Krešimir Dolić
(autor)
Eduard Vrdoljak
(autor)
Branka Petrić Miše
(autor)
